COVID-19 and immunocompromised conditions: Ongoing challenging issue | Zendy

Masoud Mardani | Zendy; Atousa Hakamifard | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

COVID-19 and immunocompromised conditions: Ongoing challenging issue

Author(s) -

Masoud Mardani,

Atousa Hakamifard

Publication year - 2021

Publication title -

european journal of inflammation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.219

H-Index - 20

eISSN - 2058-7392

pISSN - 1721-727X

DOI - 10.1177/20587392211016114

Subject(s) - covid-19 , immune system , coronavirus , medicine , immunology , intensive care medicine , betacoronavirus , virology , outbreak , disease , infectious disease (medical specialty) , pathology

One of the most serious complications of COVID-19 is the development of uncontrolled production of cytokines that poses a major factor contributing to COVID-19 morbidity and mortality. The exact effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on clinical and biochemical course of in patients with underlying immune compromised conditions is not well known with recent available data. The present letter aimed to draw attention to COVID-19 in immune deficiency.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research